Biomarker discovery from we to me: Is learning from each patient a new approach?

The immune response is a dynamic multistep process, with a complex system regulation. Identification of predictive biomarkers is therefore challenging. Deep investigation of an exceptional responder to pembrolizumab in ovarian cancer identifies new mechanism of response and highlights the power of individualized medicine strategy.

https://ift.tt/2uoekec